Impact of Schistosoma mansoni on Malaria Transmission in Sub-Saharan Africa

PLoS Neglected Tropical Diseases

Volumn 8, Issue 10, 2014, Pages

  Ndeffo Mbah, Martial L ^a   Skrip, Laura ^a   Greenhalgh, Scott ^a   Hotez, Peter ^b   Galvani, Alison P ^a  

^a YALE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ARTICLE; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; MALARIA; MATHEMATICAL MODEL; MIXED INFECTION; MORTALITY; NONHUMAN; PARASITE IDENTIFICATION; PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; ANIMAL; CHILD; COINFECTION; DEMOGRAPHY; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MALE; PARASITOLOGY; PRESCHOOL CHILD; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS; THEORETICAL MODEL; TRANSMISSION;

AFRICA SOUTH OF THE SAHARA; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; COINFECTION; HUMANS; IMMUNOLOGIC TESTS; INCIDENCE; MALARIA; MALE; MODELS, THEORETICAL; PRAZIQUANTEL; PREVALENCE; RESIDENCE CHARACTERISTICS; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 84920532208     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003234     Document Type: Article

References (84)

1. Sambo LG, Ki-Zerbo G, Kirigia JM, (2011) Malaria control in the African Region: perceptions and viewspoints on proceedings of the Africa Leaders Malaria Alliance (ALMA). BMC Proc 5 Suppl 5: S3 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=3254897&tool=pmcentrez&rendertype=abstract. Accessed 24 May 2013.
2. Stensgaard A-S, Utzinger J, Vounatsou P, Hürlimann E, Schur N, et al. (2011) Large-scale determinants of intestinal schistosomiasis and intermediate host snail distribution across Africa: Does climate matter? Acta Trop null Available: dx.doi.org/10.1016/j.actatropica.2011.11.010. Accessed 28 June 2013.
3. Hürlimann E, Schur N, Boutsika K, Stensgaard A-S, Laserna de Himpsl M, et al. (2011) Toward an open-access global database for mapping, control, and surveillance of neglected tropical diseases. PLoS Negl Trop Dis 5: e1404 Available: dx.plos.org/10.1371/journal.pntd.0001404. Accessed 30 June 2013.
4. Van der Werf MJ, de Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125–139 Available: ncbi.nlm.nih.gov/pubmed/12745133. Accessed 12 November 2012.
5. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, et al. (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 3: e102 Available: dx.plos.org/10.1371/journal.pmed.0030102. Accessed 3 June 2013.
6. Sokhna C, Le Hesran J-Y, Mbaye PA, Akiana J, Camara P, et al. (2004) Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar J 3: 43 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=538284&tool=pmcentrez&rendertype=abstract. Accessed 30 May 2013.
7. Nacher M, (2011) Interactions between worms and malaria: good worms or bad worms? Malar J 10: 259 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=3192711&tool=pmcentrez&rendertype=abstract. Accessed 15 June 2013.
8. Sangweme DT, Midzi N, Zinyowera-Mutapuri S, Mduluza T, Diener-West M, et al. (2010) Impact of schistosome infection on Plasmodium falciparum Malariometric indices and immune correlates in school age children in Burma Valley, Zimbabwe. PLoS Negl Trop Dis 4: e882 Available: dx.plos.org/10.1371/journal.pntd.0000882. Accessed 29 May 2013.
9. Druilhe P, Tall A, Sokhna C, (2005) Worms can worsen malaria: towards a new means to roll back malaria? Trends Parasitol 21: 359–362 Available: ncbi.nlm.nih.gov/pubmed/15967721. Accessed 24 May 2013.
10. Hartgers FC, Obeng BB, Kruize YCM, Dijkhuis A, McCall M, et al. (2009) Responses to malarial antigens are altered in helminth-infected children. J Infect Dis 199: 1528–1535 Available: jid.oxfordjournals.org/content/199/10/1528.long. Accessed 26 May 2013.
11. Helmby H, Kullberg M, Troye-Blomberg M, (1998) Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect Immun 66: 5167–5174 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=108644&tool=pmcentrez&rendertype=abstract. Accessed 5 July 2013.
12. Su Z, Segura M, Morgan K, Loredo-Osti JC, Stevenson MM, (2005) Impairment of protective immunity to blood-stage malaria by concurrent nematode infection. Infect Immun 73: 3531–3539 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=1111846&tool=pmcentrez&rendertype=abstract. Accessed 5 July 2013.
13. Maizels RM, Pearce EJ, Artis D, Yazdanbakhsh M, Wynn TA, (2009) Regulation of pathogenesis and immunity in helminth infections. J Exp Med 206: 2059–2066 Available: jem.rupress.org/content/206/10/2059.full. Accessed 4 June 2013.
14. Osada Y, Kanazawa T, (2011) Schistosome: its benefit and harm in patients suffering from concomitant diseases. J Biomed Biotechnol 2011: 264173 Available: europepmc.org/articles/PMC3216407. Accessed 5 July 2013.
15. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, et al. (2008) Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 372: 1545–1554 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2607025&tool=pmcentrez&rendertype=abstract. Accessed 21 May 2013.
16. Barnes KI, Chanda P, Ab Barnabas G, (2009) Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J 8 Suppl 1: S8 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2760243&tool=pmcentrez&rendertype=abstract. Accessed 14 June 2013.
17. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ, (2008) Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 7: 125 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2491628&tool=pmcentrez&rendertype=abstract. Accessed 30 May 2013.
18. Okell LC, Drakeley CJ, Bousema T, Whitty CJM, Ghani AC, (2008) Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 5: e226 discussion e226 Available: dx.plos.org/10.1371/journal.pmed.0050226. Accessed 30 May 2013.
19. King CH, Dickman K, Tisch DJ, (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561–1569 Available: ncbi.nlm.nih.gov/pubmed/15866310. Accessed 13 November 2012.
20. WHO (2011) Helminth control in school-age children. A guide for managers of control programmes. Preventive Chemotherapy and Transmission Control (PCT), Department of Control of Neglected Tropical Diseases (NTD). Geneva. Available: whqlibdoc.who.int/publications/2011/9789241548267_eng.pdf.
21. Fenwick A, (2012) The global burden of neglected tropical diseases. Public Health 126: 233–236 Available: ncbi.nlm.nih.gov/pubmed/22325616. Accessed 11 November 2012.
22. Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, et al. (2007) Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg 77: 88–98 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2637949&tool=pmcentrez&rendertype=abstract. Accessed 19 June 2013.
23. Friis H, Mwaniki D, Omondi B, Muniu E, Magnussen P, et al. (1997) Serum retinol concentrations and Schistosoma mansoni, intestinal helminths, and malarial parasitemia: a cross-sectional study in Kenyan preschool and primary school children. Am J Clin Nutr 66: 665–671 Available: ajcn.nutrition.org/content/66/3/665.short. Accessed 21 April 2014.
24. Naus CWA, Jones FM, Satti MZ, Joseph S, Riley EM, et al. (2003) Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum. J Infect Dis 187: 1272–1282 Available: jid.oxfordjournals.org/content/187/8/1272.short. Accessed 21 April 2014.
25. Booth M, Vennervald BJ, Butterworth AE, Kariuki HC, Amaganga C, et al. (2004) Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children. BMC Med 2: 36 Available: biomedcentral.com/1741-7015/2/36. Accessed 21 April 2014.
26. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, et al. (2010) Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 7: 17 Available: dx.plos.org/10.1371/journal.pmed.1000324. Accessed 24 May 2013.
27. Riley S, Carabin H, Marshall C, Olveda R, Willingham AL, et al. (2005) Estimating and modeling the dynamics of the intensity of infection with Schistosoma japonicum in villagers of Leyte, Philippines. Part II: Intensity-specific transmission of S. japonicum. The schistosomiasis transmission and ecology project. Am J Trop Med Hyg 72: 754–761 Available: ncbi.nlm.nih.gov/pubmed/15964960. Accessed 6 July 2013.
28. Gurarie D, King CH, Wang X, (2010) A new approach to modelling schistosomiasis transmission based on stratified worm burden. Parasitology 137: 1951–1965 doi:10.1017/S0031182010000867
29. King CH, Olbrych SK, Soon M, Singer ME, Carter J, et al. (2011) Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis 5: e1321 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=3176745&tool=pmcentrez&rendertype=abstract. Accessed 4 June 2013.
30. Tukahebwa EM, Vennervald BJ, Nuwaha F, Kabatereine NB, Magnussen P, (2013) Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda. Trans R Soc Trop Med Hyg 107: 397–404 Available: ncbi.nlm.nih.gov/pubmed/23596262. Accessed 6 July 2013.
31. Hay SI, Guerra CA, Tatem AJ, Atkinson PM, Snow RW, (2005) Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol 3: 81–90 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=3130901&tool=pmcentrez&rendertype=abstract. Accessed 24 March 2014.
32. Nacher M, (2001) Malaria vaccine trials in a wormy world. Trends Parasitol 17: 563–565 Available: ncbi.nlm.nih.gov/pubmed/11756019. Accessed 10 July 2013.
33. Wilson S, Dunne DW, (2012) Advances in our understanding of the epidemiology of Plasmodium and schistosome infection: informing coinfection studies. Curr Opin HIV AIDS 7: 225–230 Available: ncbi.nlm.nih.gov/pubmed/22327411. Accessed 11 July 2013.
34. Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, et al. (2013) Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med 368: 1111–1120 Available: ncbi.nlm.nih.gov/pubmed/23514288. Accessed 13 November 2013.
35. Curti E, Kwityn C, Zhan B, Gillespie P, Brelsford J, et al. (2013) Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: A vaccine candidate for human intestinal schistosomiasis. Hum Vaccin Immunother 9 Available: ncbi.nlm.nih.gov/pubmed/23899507. Accessed 18 November 2013.
36. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A, (2010) Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 8: 814–826 Available: dx.doi.org/10.1038/nrmicro2438. Accessed 7 November 2013.
37. Wilson S, Vennervald BJ, Kadzo H, Ireri E, Amaganga C, et al. (2007) Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection. Trop Med Int Health 12: 1442–1449 Available: ncbi.nlm.nih.gov/pubmed/18076550. Accessed 4 July 2013.
38. Filipe JAN, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC, (2007) Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol 3: e255 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2230683&tool=pmcentrez&rendertype=abstract. Accessed 24 May 2013.
39. Doolan DL, Dobaño C, Baird JK, (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13–36 Table of Contents. Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2620631&tool=pmcentrez&rendertype=abstract. Accessed 24 May 2013.
40. Adegnika AA, Kremsner PG, (2012) Epidemiology of malaria and helminth interaction: a review from 2001 to 2011. Curr Opin HIV AIDS 7: 221–224 Available: ncbi.nlm.nih.gov/pubmed/22418449. Accessed 11 July 2013.
41. Graham AL, (2008) Ecological rules governing helminth-microparasite coinfection. Proc Natl Acad Sci U S A 105: 566–570 Available: pnas.org/content/105/2/566.short. Accessed 29 May 2013.
42. Boel M, Carrara VI, Rijken M, Proux S, Nacher M, et al. (2010) Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border. PLoS Negl Trop Dis 4: e887 Available: dx.plos.org/10.1371/journal.pntd.0000887. Accessed 12 July 2013.
43. Dreyfuss ML, Stoltzfus RJ, Shrestha JB, Pradhan EK, LeClerq SC, et al. (2000) Hookworms, malaria and vitamin A deficiency contribute to anemia and iron deficiency among pregnant women in the plains of Nepal. J Nutr 130: 2527–2536 Available: ncbi.nlm.nih.gov/pubmed/11015485. Accessed 12 July 2013.
44. Booth M, Vennervald BJ, Kenty L, Butterworth AE, Kariuki HC, et al. (2004) Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infect Dis 4: 13 Available: biomedcentral.com/1471-2334/4/13. Accessed 23 April 2014.
45. Ajanga A, Lwambo NJS, Blair L, Nyandindi U, Fenwick A, et al. (2006) Schistosoma mansoni in pregnancy and associations with anaemia in northwest Tanzania. Trans R Soc Trop Med Hyg 100: 59–63 Available: trstmh.oxfordjournals.org/content/100/1/59.abstract. Accessed 5 April 2014.
46. Briand V, Watier L, LE Hesran J-Y, Garcia A, Cot M, (2005) Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children? Am J Trop Med Hyg 72: 702–707 Available: ncbi.nlm.nih.gov/pubmed/15964953. Accessed 12 July 2013.
47. Sang HC, Muchiri G, Ombok M, Odiere MR, Mwinzi PN, (2014) Schistosoma haematobium hotspots in south Nyanza, western Kenya: prevalence, distribution and co-endemicity with Schistosoma mansoni and soil-transmitted helminths. Parasit Vectors 7: 125 Available: parasitesandvectors.com/content/7/1/125. Accessed 23 April 2014.
48. McCullough FS, (1972) The distribution of Schistosoma mansoni and S. haematobium in East Africa. Trop Geogr Med 24: 199–207 Available: ncbi.nlm.nih.gov/pubmed/4673849. Accessed 23 April 2014.
49. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106–1118 Available: sciencedirect.com/science/article/pii/S0140673606694403. Accessed 1 May 2014.
50. Spear RC, (2012) Internal versus external determinants of Schistosoma japonicum transmission in irrigated agricultural villages. J R Soc Interface 9: 272–282 Available: rsif.royalsocietypublishing.org/content/9/67/272.full. Accessed 5 May 2014.
51. Mupfasoni D, Karibushi B, Koukounari A, Ruberanziza E, Kaberuka T, et al. (2009) Polyparasite helminth infections and their association to anaemia and undernutrition in Northern Rwanda. PLoS Negl Trop Dis 3: e517 Available: dx.plos.org/10.1371/journal.pntd.0000517. Accessed 12 July 2013.
52. Nguhiu PN, Kariuki HC, Magambo JK, Kimani G, Mwatha JK, et al. (2009) Intestinal polyparasitism in a rural Kenyan community. East Afr Med J 86: 272–278 Available: ncbi.nlm.nih.gov/pubmed/20358789. Accessed 12 July 2013.
53. Brooker S, Clements ACA, Hotez PJ, Hay SI, Tatem AJ, et al. (2006) The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J 5: 99 Available: malariajournal.com/content/5/1/99. Accessed 25 April 2014.
54. Raso G, Vounatsou P, Singer BH, N'Goran EK, Tanner M, et al. (2006) An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc Natl Acad Sci U S A 103: 6934–6939 Available: pnas.org/content/103/18/6934. Accessed 25 April 2014.
55. Slater HC, Gambhir M, Parham PE, Michael E, (2013) Modelling co-infection with malaria and lymphatic filariasis. PLoS Comput Biol 9: e1003096 Available: dx.plos.org/10.1371/journal.pcbi.1003096. Accessed 2 July 2013.
56. Manga L, (2002) Vector-control synergies, between “roll back malaria” and the Global Programme to Eliminate Lymphatic Filariasis, in the African region. Ann Trop Med Parasitol 96 Suppl 2: S129–32 Available: ncbi.nlm.nih.gov/pubmed/12630402. Accessed 25 April 2014.
57. Prasittisuk C, (2002) Vector-control synergies, between “roll back malaria” and the Global Programme to Eliminate Lymphatic Filariasis, in South-east Asia. Ann Trop Med Parasitol 96 Suppl 2: S133–7 Available: ncbi.nlm.nih.gov/pubmed/12630409. Accessed 25 April 2014.
58. Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, et al. (2011) Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis 5: e1396 Available: dx.plos.org/10.1371/journal.pntd.0001396. Accessed 1 November 2012.
59. Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, et al. (2006) Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20: 593–600 Available: ncbi.nlm.nih.gov/pubmed/16470124. Accessed 12 November 2012.
60. Downs JA, van Dam GJ, Changalucha JM, Corstjens PLAM, Peck RN, et al. (2012) Association of Schistosomiasis and HIV infection in Tanzania. Am J Trop Med Hyg 87: 868–873 Available: ncbi.nlm.nih.gov/pubmed/23033399. Accessed 25 September 2013.
61. Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, et al. (2013) Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc Natl Acad Sci U S A 110: 7952–7957 Available: pnas.org/content/110/19/7952.abstract. Accessed 24 May 2013.
62. Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, et al. (2013) Potential Cost-Effectiveness of Schistosomiasis Treatment for Reducing HIV Transmission in Africa - The Case of Zimbabwean Women. PLoS Negl Trop Dis 7: e2346 Available: dx.plos.org/10.1371/journal.pntd.0002346. Accessed 16 September 2013.
63. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Shuhua X, et al. (2000) Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355: 1320–1325 Available: sciencedirect.com/science/article/pii/S0140673600021140. Accessed 4 December 2013.
64. Liu R, Dong H-F, Guo Y, Zhao Q-P, Jiang M-S, (2011) Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors 4: 201 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=3207908&tool=pmcentrez&rendertype=abstract. Accessed 10 April 2014.
65. Pérez del Villar L, Burguillo FJ, López-Abán J, Muro A, (2012) Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS One 7: e45867 Available: plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0045867#pone-0045867-g007. Accessed 21 April 2014.
66. Obonyo CO, Muok EMO, Mwinzi PNM, (2010) Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis 10: 603–611 Available: sciencedirect.com/science/article/pii/S1473309910701614. Accessed 22 April 2014.
67. Keiser J, Xiao S-H, Smith T, Utzinger J, (2009) Combination chemotherapy against Clonorchis sinensis: experiments with artemether, artesunate, OZ78, praziquantel, and tribendimidine in a rat model. Antimicrobial Agents and Chemotherapy 53: 3770–3776 Available: pnas.org/content/110/19/7952.abstract. Accessed 14 August 2014.
68. Hou X-Y, McManus D, Gray D, Balen J, Luo X-S, et al. (2008) A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute Schistosomiasis japonica in China. Bulletin of the World Health Organization 86: 788–795 Available: plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0002975. Accessed 14 August 2014.
69. Keiser J, Silué K, Adiossan L, N'Guessan N, Monsan N, et al. (2014) Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial. PLoS Neglected Tropical Diseases 8: e2975 Available: plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0002975. Accessed 14 August 2014.
70. Mutapi F, Roussilhon C, Mduluza T, Druilhe P, (2007) Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem Inst Oswaldo Cruz 102: 405–409 Available: ncbi.nlm.nih.gov/pubmed/17568947. Accessed 21 April 2014.
71. Gu W, Mbogo CM, Githure JI, Regens JL, Killeen GF, et al. (2003) Low recovery rates stabilize malaria endemicity in areas of low transmission in coastal Kenya. Acta Trop 86: 71–81 Available: ncbi.nlm.nih.gov/pubmed/12711106. Accessed 6 July 2013.
72. Le Port A, Cot M, Etard J-F, Gaye O, Migot-Nabias F, et al. (2008) Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Malar J 7: 193 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2567330&tool=pmcentrez&rendertype=abstract. Accessed 9 August 2013.
73. Miller MJ, (1958) Observations on the natural history of malaria in the semi-resistant West African. Trans R Soc Trop Med Hyg 52: 152–168 Available: ncbi.nlm.nih.gov/pubmed/13543904. Accessed 2 July 2013.
74. Falk N, Maire N, Sama W, Owusu-Agyei S, Smith T, et al. (2006) Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg 74: 944–950 Available: ncbi.nlm.nih.gov/pubmed/16760501. Accessed 6 July 2013.
75. Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, et al. (2009) Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 4: e6358 Available: dx.plos.org/10.1371/journal.pone.0006358. Accessed 29 May 2013.
76. Watkins WM, Mberu EK, Winstanley PA, Plowe C V, (1997) The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today 13: 459–464 Available: ncbi.nlm.nih.gov/pubmed/15275132. Accessed 6 July 2013.
77. Ruebush TK, Kern MK, Campbell CC, Oloo AJ, (1995) Self-treatment of malaria in a rural area of western Kenya. Bull World Health Organ 73: 229–236 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=24l86763&too=pmcentrez&rendertype=abstract. Accessed 5 December 2013.
78. Espino F, Manderson L, (2000) Treatment seeking for malaria in Morong, Bataan, The Philippines. Soc Sci Med 50: 1309–1316 Available: sciencedirect.com/science/article/pii/S0277953699003792. Accessed 8 August 2014.
79. Ross A, Killeen G, Smith T, (2006) Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. Am J Trop Med Hyg 75: 32–37 Available: ncbi.nlm.nih.gov/pubmed/16931813. Accessed 6 July 2013.
80. Mangal TD, Paterson S, Fenton A, (2008) Predicting the impact of long-term temperature changes on the epidemiology and control of schistosomiasis: a mechanistic model. PLoS One 3: e1438 Available: dx.plos.org/10.1371/journal.pone.0001438. Accessed 8 January 2013.
81. Spear RC, Hubbard A, Liang S, Seto E, (2002) Disease transmission models for public health decision making: toward an approach for designing intervention strategies for Schistosomiasis japonica. Environ Health Perspect 110: 907–915 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=124099l1&tool=pmcentrez&rendertype=abstract. Accessed 8 January 2013.
82. Hallett TB, Gregson S, Mugurungi O, Gonese E, Garnett GP, (2009) Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics 1: 108–117 Available: ncbi.nlm.nih.gov/pubmed/21352758. Accessed 4 December 2012.
83. Odiere MR, Rawago FO, Ombok M, Secor WE, Karanja DMS, et al. (2012) High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya. Parasit Vectors 5: 278 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=3523971&tool=pmcentrez&rendertype=abstract. Accessed 29 May 2013.
84. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, et al. (2007) Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 5: 27 Available: pubmedcentral.nih.gov/articlerender.fcgi?artid=2014753&tool=pmcentrez&rendertype=abstract. Accessed 6 July 2013.